Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

Higher apelin-12 levels may indicate more severe acne.

Multimedia education greatly improves women's knowledge and management of PCOS.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

A very low-calorie ketogenic diet led to weight loss and improved metabolic and hormonal health in obese men, with better sperm motility.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.